MRC Epidemiology Unit
People who are less likely to put on excess fat around their hips due to their genes are at higher risk of type 2 diabetes and heart attacks, according to […]
New drugs could reduce risk of heart disease and diabetes when added to statins, according to genetic study simulating clinical trial
New drugs that lower levels of triglycerides (a type of fat) in blood could further reduce the risk of heart attack when added to statins. These new drugs, which are […]
Helmholtz International Fellow Award for Dr Claudia Langenberg
Dr Claudia Langenberg, a Programme Leader with our Aetiology of Diabetes and Related Metabolic disorders programme, is one of five scientists to win this year’s Helmholtz International Fellow Award. This […]
How genetic studies are helping to explain the global surge of type 2 diabetes
Type 2 diabetes affects hundreds of millions of people worldwide and understanding its causes is essential to stem the rapid increase in the number of people affected by this chronic […]
First genes that influence muscle strength in humans identified
Common genetic factors that influence muscle strength in humans have been identified for the first time in a study led by researchers from the University of Cambridge and published today […]
Generation Genome – providing the knowledge for disease prevention and treatment.
Yesterday Professor Sally Davies, the Chief Medical Officer (CMO) for England, published Generation Genome, the Chief Medical Officer’s annual report for 2016. In her report she takes a detailed look […]
Genetic differences in amino acid metabolism are linked to a higher risk of type 2 diabetes
A study published today in the journal PLOS Medicine has identified the five genetic variants associated with higher levels of the branched-chain amino acids isoleucine, leucine and valine. The researchers […]
Inability to safely store fat increases risk of diabetes and heart disease
A large-scale genetic study has provided strong evidence that the development of insulin resistance – a risk factor for type 2 diabetes and heart attacks and one of the key […]
New genetic analysis provides insight into side effects of cholesterol lowering drugs
A new meta-analysis of genetic association studies, published today in the Journal of the American Medical Association (JAMA), is shedding light on the mechanisms through which LDL-cholesterol lowering drugs can […]
Genetic approach could help identify side-effects at early stages of drug development
An approach that could reduce the chances of drugs failing during the later stages of clinical trials has been demonstrated by a collaboration between the University of Cambridge and pharmaceutical […]